Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Inborn errors of metabolism
Congenital disorder of glycosylation
Congenital disorder of glycosylation (CDG) is a fast growing group of inborn errors of metabolism characterized by defective activity of enzymes that participate in glycosylation (modification of proteins and other macromolecules by adding and processing of oligosaccharide side chains). CDG is comprised of phenotypically diverse disorders affecting multiple systems including the central nervous system, muscle function, immunity, endocrine system, and coagulation. The numerous entities in this group are subdivided, based on the synthetic pathway affected, into disorder of protein N-glycosylation, disorder of protein O-glycosylation, disorder of multiple glycosylation, and disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
-
Disorder of protein O-glycosylation 0 trials · 13 incl. sub-types Sub-types →
-
Disorder of multiple glycosylation 0 trials · 9 incl. sub-types Sub-types →
-
Congenital disorder of glycosylation type I 0 trials · 7 incl. sub-types Sub-types →
-
Disorder of protein N-glycosylation 0 trials · 7 incl. sub-types Sub-types →
-
Congenital disorder of glycosylation type II 0 trials · 3 incl. sub-types Sub-types →
-
Larsen-like syndrome, B3GAT3 type 0 trials